| Hansen Chiropractic Wellness Center, Llc | |
|
1454 Colfax St, Blair, NE 68008-2021 | |
| (402) 426-3663 | |
| (402) 625-0043 |
| Full Name | Hansen Chiropractic Wellness Center, Llc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 1454 Colfax St, Blair, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649696519 | NPI | - | NPPES |
| 10025493800 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1456 (Nebraska) | Primary |
| Provider Name | Benjamin W Hansen |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1114059789 PECOS PAC ID: 5890899140 Enrollment ID: I20070327000472 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
A recent study appearing in the November issue of Journal of American Geriatrics Society revealed that centenarian offspring (children of parents who lived to be at least 97 years old) retain important cardiovascular advantages from their parents compared to a similarly-aged cohort.
The Lee Company continues to redefine miniature fluidics with the introduction of an even more compact High Density Interface (HDI) solenoid valve.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.
› Verified 4 days ago
| Provider Name | Ty Thomas Dworak |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1437397593 PECOS PAC ID: 9537224076 Enrollment ID: I20090216000503 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
A recent study appearing in the November issue of Journal of American Geriatrics Society revealed that centenarian offspring (children of parents who lived to be at least 97 years old) retain important cardiovascular advantages from their parents compared to a similarly-aged cohort.
The Lee Company continues to redefine miniature fluidics with the introduction of an even more compact High Density Interface (HDI) solenoid valve.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.
› Verified 4 days ago
| Provider Name | Jeffrey S Groene |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1376565655 PECOS PAC ID: 4587627526 Enrollment ID: I20140408000122 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
A recent study appearing in the November issue of Journal of American Geriatrics Society revealed that centenarian offspring (children of parents who lived to be at least 97 years old) retain important cardiovascular advantages from their parents compared to a similarly-aged cohort.
The Lee Company continues to redefine miniature fluidics with the introduction of an even more compact High Density Interface (HDI) solenoid valve.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.
› Verified 4 days ago
| Provider Name | Amber L Wells |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1568821387 PECOS PAC ID: 1850712001 Enrollment ID: I20200527000148 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
A recent study appearing in the November issue of Journal of American Geriatrics Society revealed that centenarian offspring (children of parents who lived to be at least 97 years old) retain important cardiovascular advantages from their parents compared to a similarly-aged cohort.
The Lee Company continues to redefine miniature fluidics with the introduction of an even more compact High Density Interface (HDI) solenoid valve.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.
› Verified 4 days ago
| Provider Name | Ryan M Umland |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1477270825 PECOS PAC ID: 5597136762 Enrollment ID: I20230126000526 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
A recent study appearing in the November issue of Journal of American Geriatrics Society revealed that centenarian offspring (children of parents who lived to be at least 97 years old) retain important cardiovascular advantages from their parents compared to a similarly-aged cohort.
The Lee Company continues to redefine miniature fluidics with the introduction of an even more compact High Density Interface (HDI) solenoid valve.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hansen Chiropractic Wellness Center, Llc 1454 Colfax St, Blair, NE 68008-2021 Ph: (402) 660-1770 | Hansen Chiropractic Wellness Center, Llc 1454 Colfax St, Blair, NE 68008-2021 Ph: (402) 426-3663 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
A recent study appearing in the November issue of Journal of American Geriatrics Society revealed that centenarian offspring (children of parents who lived to be at least 97 years old) retain important cardiovascular advantages from their parents compared to a similarly-aged cohort.
The Lee Company continues to redefine miniature fluidics with the introduction of an even more compact High Density Interface (HDI) solenoid valve.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.
› Verified 4 days ago
Midwest Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 753 Washington St, Blair, NE 68008 Phone: 402-426-9211 Fax: 402-426-9244 | |
Dr. Theodore L. Japp, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 650 S 19th St, Blair, NE 68008 Phone: 402-533-1011 | |
Dr. Benjamin William Hansen, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1454 Colfax St, Blair, NE 68008 Phone: 402-426-3663 Fax: 402-426-5141 | |
Dr. Sean Michael Connor, DC, BA, BS Chiropractor Medicare: Medicare Enrolled Practice Location: 924 Grant St, Blair, NE 68008 Phone: 402-426-0404 Fax: 402-939-0773 | |
Kelly Christine Conn, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 924 Grant St, Blair, NE 68008 Phone: 402-426-0404 | |
Blair Chiropractic Centre Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1526 Washington St, Blair, NE 68008 Phone: 402-426-4443 Fax: 402-426-4604 | |
Dr. Faye Coles Jones, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1526 Washington St, Blair, NE 68008 Phone: 402-426-4443 Fax: 402-426-4604 |